Adverse Cutaneous Drug Reactions to Cardiovascular Drugs (Record no. 8006)

MARC details
000 -LEADER
fixed length control field 03439nam a22002777a 4500
003 - CONTROL NUMBER IDENTIFIER
control field OSt
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20240305192526.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 220802b |||||||| |||| 00| 0 eng d
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 1447165365
International Standard Book Number 9781447165361
040 ## - CATALOGING SOURCE
Transcribing agency DLC
082 ## - DEWEY DECIMAL CLASSIFICATION NUMBER
Classification number 616.5 OZK
100 ## - MAIN ENTRY--PERSONAL NAME
Personal name Esen Özkaya
9 (RLIN) 41133
222 ## - KEY TITLE
Key title Acad Dermatol ACEIs acetazolamide Acute generalized exanthematous adverse cutaneous drug AGEP Allergy alopecia amiodarone amlodipine angioedema Angioedema/urticaria angiotensin II receptor antibodies ARBs Arch Dermatol aspirin associated beta-blockers bullous pemphigoid captopril cardiovascular drugs cause CCBs Clin Exp Dermatol clinical clopidogrel Contact Dermatitis corticosteroids cross-reactivity cutaneous adverse cutaneous drug reactions cutaneous reactions Dermatol Venereol diltiazem diuretics drug rash Drug-induced lupus erythematosus eczematous eruption edema enalapril eosinophilia and systemic erythema multiforme erythroderma exanthematous pustulosis Fixed drug eruption furosemide heparin hydrochlorothiazide hyperpigmentation hypersensitivity reactions induced lesions lichen planus Lichenoid drug eruption lichenoid eruption lisinopril LMWHs losartan maculopapular eruption methyldopa mexiletine mucosal necrosis nifedipine oral Özkaya patch test patch test reactions patients pemphigus phenytoin photopatch testing photosensitivity positive patch test propranolol Pruritus psoriasis purpura quinidine rash with eosinophilia receptor blockers rechallenge reported simvastatin statins Stevens-Johnson syndrome Stevens–Johnson subacute cutaneous lupus sulfonamide systemic symptoms therapy ticlopidine toxic epidermal necrolysis ulcers urticaria valsartan vasculitis verapamil
245 ## - TITLE STATEMENT
Title Adverse Cutaneous Drug Reactions to Cardiovascular Drugs
250 ## - EDITION STATEMENT
Edition statement illustrated
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Place of publication, distribution, etc. Department of Dermatology Istanbul University Istanbul Medical Faculty Istanbul Turkey
Name of publisher, distributor, etc. Springer
Date of publication, distribution, etc. 2014
300 ## - PHYSICAL DESCRIPTION
Extent 259 pages
520 ## - SUMMARY, ETC.
Summary, etc. Adverse cutaneous drug reactions (ACDR) are among the most frequent events in patients receiving drug therapy. Cardiovascular (CV) drugs are an important group of drugs with potential risk of developing ACDR especially in elderly as marketing of more new drugs and their prescription continue to increase. However, like with most other drugs the exact incidence of cutaneous side effects from CV drugs is difficult to estimate due to sporadic reporting. Moreover, a reliable designation of a certain drug as the cause of a certain type of reaction can rarely be made. Apart from the well-known angioedema/urticaria from ACE inhibitors, lichen planus / lichenoid reaction from beta adrenergic blockers and photosensitivity from thiazid diuretics, ACDR from CV drugs might be seen in a wide spectrum extending to rare but life-threatening conditions such as erythroderma, Stevens-Johnson syndrome, toxic epidermal necrolysis or drug hypersensitivity syndrome. In this comprehensive review, the reported types of ACDR to CV drugs will be discussed according to drug class and the type of dermatologic reaction with special emphasize on cross-reactions and the role of patch testing in diagnosis.
600 ## - SUBJECT ADDED ENTRY--PERSONAL NAME
General subdivision Medical / Dermatology
9 (RLIN) 26960
General subdivision Medical / Clinical Medicine
9 (RLIN) 26816
General subdivision Medical / Cardiology
9 (RLIN) 26817
General subdivision Medical › Dermatology
9 (RLIN) 27797
700 ## - ADDED ENTRY--PERSONAL NAME
9 (RLIN) 41134
942 ## - ADDED ENTRY ELEMENTS (KOHA)
Source of classification or shelving scheme ddc
Koha item type E-BOOKS
Holdings
Withdrawn status Lost status Source of classification or shelving scheme Damaged status Not for loan Collection Home library Current library Shelving location Date acquired Total checkouts Full call number Barcode Date last seen Price effective from Koha item type
            MWALIMU NYERERE LEARNING RESOURCES CENTRE-CUHAS BUGANDO MWALIMU NYERERE LEARNING RESOURCES CENTRE-CUHAS BUGANDO   08/02/2022   616.5 OZK EBS12250 08/02/2022 08/02/2022 E-BOOKS
Catholic University of  Health and Allied Sciences - CUHAS
Directorate of ICT @ 2024